A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
Conditions
- Heart Failure, Congestive
Interventions
- DRUG: Low Dose Bisoprolol
- DRUG: High Dose Bisoprolol
Sponsor
Merck KGaA, Darmstadt, Germany
Collaborators